FI3436034T3 - Mutantteja bordetella-kantoja ja käyttömenetelmiä - Google Patents
Mutantteja bordetella-kantoja ja käyttömenetelmiä Download PDFInfo
- Publication number
- FI3436034T3 FI3436034T3 FIEP17715426.7T FI17715426T FI3436034T3 FI 3436034 T3 FI3436034 T3 FI 3436034T3 FI 17715426 T FI17715426 T FI 17715426T FI 3436034 T3 FI3436034 T3 FI 3436034T3
- Authority
- FI
- Finland
- Prior art keywords
- subject
- composition
- pertactin
- use according
- free
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Developmental Biology & Embryology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662314843P | 2016-03-29 | 2016-03-29 | |
| PCT/EP2017/057468 WO2017167834A1 (en) | 2016-03-29 | 2017-03-29 | Mutant bordetella strains and methods for use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3436034T3 true FI3436034T3 (fi) | 2025-05-08 |
Family
ID=58488973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP17715426.7T FI3436034T3 (fi) | 2016-03-29 | 2017-03-29 | Mutantteja bordetella-kantoja ja käyttömenetelmiä |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10682377B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3436034B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6993984B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN109069535B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2017242541B2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3436034T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3027194T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI3436034T3 (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201807783UA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017167834A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2821830T3 (es) | 2006-03-10 | 2021-04-27 | Pasteur Institut | Cepas de Bordetella vivas atenuadas como vacuna de dosis única contra la tos ferina |
| DK2424564T3 (en) | 2009-04-28 | 2015-04-27 | Inserm Inst Nat De La Santé Et De La Rech Médicale | A vaccine for the prevention or treatment of a respiratory pathology allergendrevet |
| WO2017167834A1 (en) * | 2016-03-29 | 2017-10-05 | Institut Pasteur De Lille | Mutant bordetella strains and methods for use |
| CN111278456B (zh) | 2017-10-18 | 2024-08-09 | 里尔巴斯德研究所 | 表达血清3型菌毛的鲍特菌属菌株 |
| EP4196155A4 (en) | 2020-08-14 | 2025-03-19 | Iliad Biotechnologies, LLC | Lyophilized live bordetella vaccines |
| EP4247397A4 (en) | 2020-11-17 | 2024-11-06 | Iliad Biotechnologies, LLC | TREATMENT AND PREVENTION OF NEUROPATHOLOGY ASSOCIATED WITH NEURODEGENERATIVE DISEASES |
| CA3261556A1 (en) | 2022-07-22 | 2024-01-25 | Institut National de la Santé et de la Recherche Médicale | USE OF BORDETELLA STRAINS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
| WO2025257397A1 (en) | 2024-06-14 | 2025-12-18 | Institut National de la Santé et de la Recherche Médicale | Live attenuated bordetella vaccines capable of producing and secreting heterologous antigens |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6713072B1 (en) | 1987-11-02 | 2004-03-30 | Chiron S.R.L. | Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine |
| GB9115332D0 (en) * | 1991-07-16 | 1991-08-28 | Connaught Lab | Manipulation of gene copy number in bordetella |
| FR2718750B1 (fr) | 1994-04-19 | 1996-06-14 | Pasteur Institut | Protéines recombinantes de l'hémagglutinine filamenteuse de Bordetella, notamment, B. Pertussis, production et application à la production de protéines étrangères ou de principes actifs vaccinants. |
| DE69511392T2 (de) * | 1994-04-28 | 2000-03-23 | Takeda Chemical Industries, Ltd. | Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis |
| FR2754543B1 (fr) | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
| FR2840319B1 (fr) | 2002-05-30 | 2004-08-20 | Pasteur Institut | Souches de bordetella rendues deficientes par attenuation genetique |
| AU2004229527B2 (en) | 2003-04-11 | 2009-08-20 | Medimmune, Llc | Methods of preventing or treating respiratory conditions |
| ES2821830T3 (es) | 2006-03-10 | 2021-04-27 | Pasteur Institut | Cepas de Bordetella vivas atenuadas como vacuna de dosis única contra la tos ferina |
| JP2010508860A (ja) | 2006-11-15 | 2010-03-25 | フォリア バイオテック インコーポレイテッド | パパイヤモザイクウイルスに基づくインフルエンザ用ワクチン |
| WO2008118592A2 (en) | 2007-02-23 | 2008-10-02 | The Penn State Research Foundation | Use of an avirulent bordetella mutant as a live vaccine vector |
| AU2008266910A1 (en) | 2007-06-18 | 2008-12-24 | Hemispherx Biopharma, Inc. | Early intervention of viral infections with immune activators |
| DK2424564T3 (en) * | 2009-04-28 | 2015-04-27 | Inserm Inst Nat De La Santé Et De La Rech Médicale | A vaccine for the prevention or treatment of a respiratory pathology allergendrevet |
| WO2010146414A1 (en) | 2009-06-15 | 2010-12-23 | National University Of Singapore | Influenza vaccine, composition, and methods of use |
| EP2773371B1 (en) | 2011-11-02 | 2020-01-01 | National University of Singapore | Effect of an attenuated bordetella strain against allergic disease |
| CN102793915B (zh) * | 2012-07-25 | 2013-10-23 | 天津康希诺生物技术有限公司 | 一种无细胞百日咳疫苗的生产方法 |
| EP2722338A1 (en) | 2012-10-17 | 2014-04-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Novel recombinant Bordetella strains |
| WO2017167834A1 (en) * | 2016-03-29 | 2017-10-05 | Institut Pasteur De Lille | Mutant bordetella strains and methods for use |
-
2017
- 2017-03-29 WO PCT/EP2017/057468 patent/WO2017167834A1/en not_active Ceased
- 2017-03-29 CN CN201780021384.7A patent/CN109069535B/zh active Active
- 2017-03-29 AU AU2017242541A patent/AU2017242541B2/en active Active
- 2017-03-29 US US15/472,436 patent/US10682377B2/en active Active
- 2017-03-29 ES ES17715426T patent/ES3027194T3/es active Active
- 2017-03-29 JP JP2018551960A patent/JP6993984B2/ja active Active
- 2017-03-29 FI FIEP17715426.7T patent/FI3436034T3/fi active
- 2017-03-29 DK DK17715426.7T patent/DK3436034T3/da active
- 2017-03-29 EP EP17715426.7A patent/EP3436034B1/en active Active
- 2017-03-29 SG SG11201807783UA patent/SG11201807783UA/en unknown
- 2017-03-29 EP EP25158892.7A patent/EP4541809A3/en active Pending
- 2017-03-29 CN CN202210315642.5A patent/CN114767718A/zh active Pending
-
2020
- 2020-04-30 US US16/863,972 patent/US11065276B2/en active Active
-
2021
- 2021-06-02 US US17/337,367 patent/US20210290667A1/en not_active Abandoned
-
2022
- 2022-08-24 AU AU2022221438A patent/AU2022221438B2/en active Active
-
2023
- 2023-06-20 US US18/338,314 patent/US20230381224A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200323901A1 (en) | 2020-10-15 |
| ES3027194T3 (en) | 2025-06-13 |
| CN109069535B (zh) | 2022-03-18 |
| US20210290667A1 (en) | 2021-09-23 |
| US10682377B2 (en) | 2020-06-16 |
| AU2017242541A1 (en) | 2018-10-11 |
| EP4541809A3 (en) | 2025-06-25 |
| US20230381224A1 (en) | 2023-11-30 |
| WO2017167834A1 (en) | 2017-10-05 |
| CN109069535A (zh) | 2018-12-21 |
| US20170283890A1 (en) | 2017-10-05 |
| AU2017242541B2 (en) | 2022-06-30 |
| EP4541809A2 (en) | 2025-04-23 |
| AU2022221438B2 (en) | 2024-10-03 |
| US11065276B2 (en) | 2021-07-20 |
| JP2019513722A (ja) | 2019-05-30 |
| DK3436034T3 (da) | 2025-05-12 |
| EP3436034B1 (en) | 2025-03-26 |
| SG11201807783UA (en) | 2018-10-30 |
| EP3436034A1 (en) | 2019-02-06 |
| CN114767718A (zh) | 2022-07-22 |
| AU2022221438A1 (en) | 2022-10-06 |
| CA3018126A1 (en) | 2017-10-05 |
| JP6993984B2 (ja) | 2022-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3436034T3 (fi) | Mutantteja bordetella-kantoja ja käyttömenetelmiä | |
| JP2019513722A5 (cg-RX-API-DMAC7.html) | ||
| US12403188B2 (en) | Bordetella strains expressing serotype 3 fimbriae | |
| WO2020049133A1 (en) | Adenylate cyclase catalytic domain deficient bordetella strains | |
| KR102040665B1 (ko) | 약독화된 폐렴구균 균주를 포함하는 약제학적 조성물 및 이의 용도 | |
| CN106794201A (zh) | 包含新型温度敏感性分枝杆菌菌株的对分枝杆菌感染症的疫苗组合物 | |
| Sukumar et al. | Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines | |
| Mukkur et al. | Alternative whooping cough vaccines: A minireview | |
| CN117643281A (zh) | 肺炎克雷伯菌肺炎感染小鼠模型的构建方法及其应用 | |
| HK1262896A1 (en) | Mutant bordetella strains and methods for use | |
| HK1262896B (zh) | 突变型博德特氏菌属菌株及其使用方法 | |
| Ural et al. | Fecal Microbiota Transplantation Against Respiratoy Disease in Goats at Field Conditions | |
| EP4244239A1 (en) | Live attenuated strain of streptococcus pneumoniae and pharmaceutical compositions comprising a live attenuated strain of s. pneumoniae | |
| Lee et al. | RECOVERY FROM NEUROLOGIC IMPAIRMENT IN MURINE MODEL OF CORONAVIRUS-INDUCED DEMYELINATION DOES NOT DIRECTLY CORRELATE WITH IMPROVEMENT OF NEUROGENIC BLADDER DYSFUNCTION: LONG-TERM FOLLOW UP STUDY: LB-S&T-36 | |
| Rudrappa et al. | D46 CASE REPORTS IN ENVIRONMENTAL AND OCCUPATIONAL HEALTH: Hot Tub Lung. Unique Diffuse Environmental Pulmonary Lung Disease Due To Atypical Mycobacterium | |
| LI | Immuno-protection efficacy of Mtb8. 4 gene vaccine with signal peptide against TB in mice |